식품 알레르기 시장 - 세계 및 지역별 분석 : 약제 클래스별, 국가별, 지역별 - 분석과 예측(2025-2035년)

Global Food Allergy Market: Overview

Rising incidences of food allergies, growing awareness among consumers, and technological advancements in diagnostic and treatment methods are the primary drivers of market growth. Food allergies are a significant concern globally, affecting millions of individuals and leading to a growing demand for effective treatment options.

Food allergies occur when the immune system mistakenly identifies a harmless food protein as harmful. Symptoms can range from mild to life-threatening, highlighting the need for effective treatments and preventive measures. Advances in immunotherapy and other biologics are playing an important role in improving patient outcomes.

Market Lifecycle Stage

The food allergy market is in an evolving phase with substantial investment in new treatment options, such as oral immunotherapy, biologics, and genetically engineered products aimed at desensitizing patients to allergens. This shift from symptom management to more preventive treatments marks a pivotal point in the market's lifecycle.

Market Segmentation for the Global Food Allergy Market

Segmentation 1: by Drug Class

• Epinephrine
• Antihistamines
• Steroids
• Others

The global food allergy market is segmented by drug class, with each class addressing different aspects of food allergies. Antihistamines as a popular treatment for mild symptoms, contributing to consistent market demand. Steroids, used for managing inflammation, and Beta-2-agonists, which help alleviate respiratory symptoms, are also important segments, with moderate growth expected driven by their complementary roles in managing food allergy symptoms.

Segmentation 2: by Region

• North America
• Europe
• Asia-Pacific

North America holds the largest share in the global food allergy market, with the U.S. being a major contributor.

Demand - Drivers and Limitations

The global food allergy market is driven by several key factors:

• The global rise in food allergies among children and adults is likely to drive higher demand for preventive and therapeutic measures
• A stronger focus on research and development is expected to significantly contribute to the demand for advanced allergy care products
• Increased healthcare spending and government investment in infrastructure are boosting the growth of the food allergy market

Limitations:

• The lack of standardized diagnostic criteria limits the evidence on food allergy prevalence and management
• Delays in test results and the need for large blood samples, especially in children, can stifle market growth
• Risk of severe adverse reactions during treatment

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: This report highlights key trends in food allergy treatment and diagnostic services, helping companies innovate in biologics, immunotherapy, and precision medicine tailored to food allergy sufferers.

Competitive Strategy: The food allergy market is highly competitive, and pharmaceutical companies, healthcare providers, and food manufacturers can use this report to stay ahead by understanding market trends, competitors, and emerging opportunities.

Key Market Players and Competition Synopsis

The companies profiled in this report are selected based on expert insights, evaluating company coverage, product portfolio, and market penetration. Leading players in the global food allergy market include pharmaceutical companies, healthcare providers, and food manufacturers.

Table of Contents

Executive Summary

Scope of Study

Definition

Inclusion and Exclusion Criteria

1. Global Food Allergy Market: Industry Outlook

• 1.1 Market Overview and Ecosystem
• 1.2 Epidemiological Analysis of Food Allergy
  • 1.2.1 U.S.
  • 1.2.2 EU5
  • 1.2.3 Rest-of-the-World
• 1.3 Market Trends
• 1.4 Clinical Trials
  • 1.4.1 By Phase
• 1.5 Regulatory Landscape Analysis
  • 1.5.1 Legal Requirement and Framework in U.S.
  • 1.5.2 Legal Requirement and Framework in E.U.
  • 1.5.3 Legal Requirement and Framework in Asia-Pacific
  • 1.5.4 Legal Requirement and Framework in Rest-of-the-World
• 1.6 Market Dynamics
  • 1.6.1 Impact Analysis
  • 1.6.2 Market Drivers
  • 1.6.3 Market Restraints
  • 1.6.4 Market Opportunities

2. Global Food Allergy Market, by Drug Class, $Million, 2023-2035

• 2.1 Epinephrine
• 2.2 Antihistamines
• 2.3 Steroids
• 2.4 Others

3. Global Food Allergy Market, by Region, $Million, 2023-2035

• 3.1 North America
  • 3.1.1 Key Findings
  • 3.1.2 Market Dynamics
  • 3.1.3 Market Sizing and Forecast
    • 3.1.3.1 North America Food Allergy Market (by Country)
      • 3.1.3.1.1 U.S.
• 3.2 Europe
  • 3.2.1 Key Findings
  • 3.2.2 Market Dynamics
  • 3.2.3 Market Sizing and Forecast
    • 3.2.3.1 Europe Food Allergy Market (by Country)
      • 3.2.3.1.1 Germany
      • 3.2.3.1.2 France
      • 3.2.3.1.3 Italy
      • 3.2.3.1.4 U.K.
• 3.3 Asia-Pacific
  • 3.3.1 Key Findings
  • 3.3.2 Market Dynamics
  • 3.3.3 Market Sizing and Forecast
    • 3.3.3.1 Asia-Pacific Food Allergy Market (by Country)
      • 3.3.3.1.1 Japan

4. Global Food Allergy Market - Competitive Benchmarking and Company Profiles

• 4.1 Competitive Landscape
  • 4.1.1 Key Strategies and Developments by Company
    • 4.1.1.1 Funding Activities
    • 4.1.1.2 Mergers and Acquisitions
    • 4.1.1.3 Regulatory Approvals
    • 4.1.1.4 Partnerships, Collaborations and Business Expansions
  • 4.1.2 Key Developments Analysis
• 4.2 Company Profiles
  • 4.2.1 Novartis Pharmaceuticals
    • 4.2.1.1 Company Overview
    • 4.2.1.2 Product Portfolio
    • 4.2.1.3 Target Customers / End Users
    • 4.2.1.4 Key Personnels
    • 4.2.1.5 Analyst View
  • 4.2.2 F. Hoffmann-La Roche Ltd
    • 4.2.2.1 Company Overview
    • 4.2.2.2 Product Portfolio
    • 4.2.2.3 Target Customers / End Users
    • 4.2.2.4 Key Personnels
    • 4.2.2.5 Analyst View
  • 4.2.3 DBV Technologies
    • 4.2.3.1 Company Overview
    • 4.2.3.2 Product Portfolio
    • 4.2.3.3 Target Customers / End Users
    • 4.2.3.4 Key Personnels
    • 4.2.3.5 Analyst View
  • 4.2.4 Vedanta Biosciences, Inc
    • 4.2.4.1 Company Overview
    • 4.2.4.2 Product Portfolio
    • 4.2.4.3 Target Customers / End Users
    • 4.2.4.4 Key Personnels
    • 4.2.4.5 Analyst View
  • 4.2.5 Regeneron Pharmaceuticals
    • 4.2.5.1 Company Overview
    • 4.2.5.2 Product Portfolio
    • 4.2.5.3 Target Customers / End Users
    • 4.2.5.4 Key Personnels
    • 4.2.5.5 Analyst View
  • 4.2.6 Camallergy
    • 4.2.6.1 Company Overview
    • 4.2.6.2 Product Portfolio
    • 4.2.6.3 Target Customers / End Users
    • 4.2.6.4 Key Personnels
    • 4.2.6.5 Analyst View

5. Research Methodology